Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» DPV-001
DPV-001
Bristol Myers Squibb, UbiVac to assess combination immunotherapy for advanced triple-negative breast cancer
Pharmaceutical Business Review
Wed, 06/10/20 - 10:54 am
UbiVac
Bristol-Myers Squibb
clinical trials
triple negative breast cancer
DPV-001